# Assessment of the Efficacy of a Highly Standardized Ginger and Perilla Nutraceutical (Dispepril®) in Improving Gastric and Intestinal Symptoms in Patients With Functional Dyspepsia

> **NCT07655219** · NA · NOT_YET_RECRUITING · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 400 (estimated)

## Conditions studied

- Functional Dysphonia

## Interventions

- **DIETARY_SUPPLEMENT:** Dispepril® (Pharmextracta S.p.A. Pontenure, Italy)
- **COMBINATION_PRODUCT:** Half-Dose PPI Plus Dispepril®
- **DRUG:** Full-Dose Proton Pump Inhibitor

## Key facts

- **NCT ID:** NCT07655219
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-22
- **Primary completion:** 2026-11-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-06-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07655219

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07655219, "Assessment of the Efficacy of a Highly Standardized Ginger and Perilla Nutraceutical (Dispepril®) in Improving Gastric and Intestinal Symptoms in Patients With Functional Dyspepsia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07655219. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*